A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 2

Summary

The purpose of this study is to evaluate the immunogenicity and safety profile of the Avian flu vaccine with and without adjuvant 2 in healthy, young adults. The study is divided down into Parts A1, A2 and B. Groups within each Part will receive two doses of the assigned test article on Study Days 0 and 21. There will be a Safety Monitoring Committee assessment following Day 7 for each part, prior to allowing vaccination of subjects in subsequent Parts of the study.

Timeline

Start

2012-05

Primary completion

2012-08

Completion

2013-08

Drugs

Indications